Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10608825 | 1.00 | TSHR (0.43) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL11414764 | 1.00 | TSHR (0.43) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL10795533 | 1.00 | TSHR (0.43) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL798042 | 0.91 | TSHR (0.39) | TSHRALDH1A1DNM1 | |
| SCHEMBL1723662 | 0.86 | TSHR (0.41) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL997186 | 0.86 | TSHR (0.41) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL11742763 | 0.84 | TSHR (0.40) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL15266065 | 0.84 | TSHR (0.40) | TSHRALDH1A1LMNAFAAHDNM1 | |
| SCHEMBL1170088 | 0.82 | TSHR (0.33) | TSHRALDH1A1 | |
| SCHEMBL20557296 | 0.82 | TSHR (0.64) | TSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160172678-A1 | BINDER FOR NON-AQUEOUS ELECTRICITY STORAGE ELEMENT, AND NON-AQUEOUS ELECTRICITY STORAGE ELEMENT | KYORITSU CHEMICAL & CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| EP-2314657-B1 | Emissive lamps comprising metal clusters confined in molecular sieves | UNIV LEUVEN KATH (BE) | 2012-09-26 | — | — | EP | disclosed |
| EP-2162923-B1 | SOLAR CELLS | UNIV LEUVEN KATH (BE) | 2012-08-22 | — | — | EP | disclosed |
| US-8115374-B2 | Emissive lamps comprising metal clusters confined in molecular sieves | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2012-02-14 | — | — | US | disclosed |
| EP-2314657-A2 | Emissive lamps comprising metal clusters confined in molecular sieves | Katholieke Universiteit Leuven (BE) | 2011-04-27 | — | — | EP | disclosed |
| EP-2167607-B1 | LIGHT-EMITTING MATERIALS FOR ELECTROLUMINESCENT DEVICES | UNIV LEUVEN KATH (BE) | 2011-03-02 | — | — | EP | disclosed |
| US-20110018425-A1 | EMISSIVE LAMPS COMPRISING METAL CLUSTERS CONFINED IN MOLECULAR SIEVES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2011-01-27 | — | — | US | disclosed |
| EP-2167610-B1 | EMISSIVE LAMPS COMPRISING METAL CLUSTERS CONFINED IN MOLECULAR SIEVES | UNIV LEUVEN KATH (BE) | 2010-12-29 | — | — | EP | disclosed |
| EP-2165294-B1 | NEW MATERIALS FOR DATA STORAGE | UNIV LEUVEN KATH (BE) | 2010-11-10 | — | — | EP | disclosed |
| US-20100236611-A1 | SOLAR CELLS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2010-09-23 | — | — | US | disclosed |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-04-07 | — | — | US | disclosed |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040092777-A1 | Method for producing allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| US-6613813-B1 | Offset printing ink composition comprising colophony-modified phenolic resin, maleic resin, modified hydrocarbon resin, and/or colophony resin ester, and water insoluble fatty acid ester of multivalent alcohol or ethinol | BORGMANN URSULA (DE) | 2003-09-02 | — | — | US | disclosed |
| EP-0866081-A1 | GRAFTED POLYOLEFIN RESIN AND THERMOPLASTIC RESIN COMPOSITION CONTAINING THE SAME | KANEKA CORPORATION (JP) | 1998-09-23 | — | — | EP | disclosed |
| US-4678857-A | SOLVENT HAVING VERY DIFFERENT DENSITY FROM THAT OF WATER | TEXACO INC. (US) | 1987-07-07 | — | — | US | disclosed |
| US-4533742-A | USING RHODIUM CARBONYL CATALYST | TEXACO INC. (US) | 1985-08-06 | — | — | US | disclosed |
| US-4529808-A | Mixture of hydrocarbon and amide solvents | TEXACO INC. (US) | 1985-07-16 | — | — | US | disclosed |
| US-4464399-A | INFUSION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-08-07 | — | — | US | disclosed |
| US-4267262-A | MIXTURE OF CELLULOSE ACETATE AND POLYMER CONTAINING MONOESTERS OF MALEIC ACID | FUJI PHOTO FILM CO., LTD. (JP) | 1981-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | TSHR 4449/4885ALDH1A1 1665/4885LMNA 4141/4885 |
| US-20040092777-A1 | Method for producing allyl compound | CCNT1, APEX1, REV1 | TSHR 4147/4885ALDH1A1 636/4885LMNA 4173/4885 |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | CCNT1, AOC3, ATL3 | TSHR 3258/4885ALDH1A1 790/4885LMNA 3467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.